News
A new collaboration between Apertura and the National Institutes of Health (NIH) aims to advance a potential gene therapy for Niemann-Pick Disease Type C1 (NPC1), a rare and often fatal neurodegenerative disorder. Under a newly signed Cooperative Research and Development Agreement (CRADA), NIH and
If you are interested in collaborating on an oncology-related technology, don’t miss the National Cancer Institute’s (NCI) Michael Salgaller and the Office of Technology Transfer’s (OTT) Steven Ferguson’s presentation at the MedInvest Oncology Investor Conference from December 14-15, 2022. This
Are you interested in licensing or collaborating on a new immunotherapy method to target solid tumors? The National Cancer Institute’s distinguished inventor, Dr. John Schiller, will be discussing this invention and fielding questions on December 14, 2022. This technology involves the injection of
Have you missed networking and learning from other technology transfer professionals in person? The Federal Laboratory Consortium (FLC) is here to help – they are hosting their first in-person National Meeting in three years! The 2023 FLC National Meeting will be held from March 28-30 th in